Government in the Sunshine Act Meeting Notice, 22146 [2011-9726]

Download as PDF 22146 Federal Register / Vol. 76, No. 76 / Wednesday, April 20, 2011 / Notices named as respondents Astra Tobacco Corporation of Chapel Hill, North Carolina; delfortgroup AG of Traun, Austria; LIPtec GmbH and Julius Glatz GmbH of Neidenfels, Germany. On March 22, 2011, the ALJ issued an ID (Order No. 5) granting complainant Schweitzer’s motion to amend the complaint and notice of the investigation to add seven additional respondents to the investigation. The new respondents are Dosal Tobacco Corp.; Farmer’s Tobacco Co.; S&M Brands, Inc.; Tantus Tobacco, LLC; KneX Worldwide, LLC; Dr. Franz Feurstein GmbH; and PapierfabrikWattens GmbH & Co. KG. No party petitioned for review of the subject ID. The Commission has determined not to review the ID. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in section 210.42(h) of the Commission’s Rules of Practice and Procedure (19 CFR 210.42(h)). By order of the Commission: Issued: April 18, 2011. William R. Bishop, Hearings and Meetings Coordinator. By order of the Commission. Issued: April 15, 2011. James R. Holbein, Acting Secretary to the Commission. Cocaine (9041) .............................. Ecgonine (9180) ............................ [FR Doc. 2011–9584 Filed 4–19–11; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [USITC SE–11–010] Government in the Sunshine Act Meeting Notice United States International Trade Commission. TIME AND DATE: April 28, 2011 at 11 a.m. PLACE: Room 110, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agendas for future meetings: none. 2. Minutes. 3. Ratification List. 4. Vote in Inv. Nos. 701–TA–475 and 731–TA–1177 (Final) (Aluminum Extrusions from China). The Commission is currently scheduled to transmit its determinations and Commissioners’ opinions to the Secretary of Commerce on or before May 13, 2011. 5. Outstanding action jackets: none. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. Earlier Notification of this meeting was not possible. srobinson on DSKHWCL6B1PROD with NOTICES AGENCY HOLDING THE MEETING: VerDate Mar<15>2010 17:52 Apr 19, 2011 Jkt 223001 Drug Enforcement Administration (DEA) as a bulk manufacturer of the following basic classes of controlled substances: [FR Doc. 2011–9726 Filed 4–18–11; 4:15 pm] Drug BILLING CODE 7020–02–P Amphetamine (1100) .................... Phenylacetone (8501) .................. Schedule II II DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 24, 2011, Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than June 20, 2011. Dated: April 13, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than June 20, 2011. Dated: April 13, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–9610 Filed 4–19–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated June 17, 2010, and published in the Federal Register on June 28, 2010, 75 FR 36679, Lin Zhi International Inc., 670 Almanor Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: [FR Doc. 2011–9619 Filed 4–19–11; 8:45 am] Drug Schedule BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 3, 2010, Noramco Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801– 4485, made application by letter to the PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Tetrahydrocannabinols (7370) ..... 3,4Methylenedioxymethamphetamine (MDMA) (7405). Cocaine (9041) ............................. Oxycodone (9143) ........................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... I I II II II II II II The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing. E:\FR\FM\20APN1.SGM 20APN1

Agencies

[Federal Register Volume 76, Number 76 (Wednesday, April 20, 2011)]
[Notices]
[Page 22146]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9726]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-11-010]


Government in the Sunshine Act Meeting Notice

AGENCY HOLDING THE MEETING: United States International Trade 
Commission.

TIME AND DATE: April 28, 2011 at 11 a.m.

PLACE: Room 110, 500 E Street SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

STATUS: Open to the public.

MATTERS TO BE CONSIDERED:
    1. Agendas for future meetings: none.
    2. Minutes.
    3. Ratification List.
    4. Vote in Inv. Nos. 701-TA-475 and 731-TA-1177 (Final) (Aluminum 
Extrusions from China). The Commission is currently scheduled to 
transmit its determinations and Commissioners' opinions to the 
Secretary of Commerce on or before May 13, 2011.
    5. Outstanding action jackets: none.
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting. Earlier Notification of this meeting 
was not possible.

    By order of the Commission:

    Issued: April 18, 2011.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. 2011-9726 Filed 4-18-11; 4:15 pm]
BILLING CODE 7020-02-P